GTP-14564

Cat. No. M43513

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

GTP-14564 is a tyrosine kinase inhibitor targeting to internal tandem duplication (ITD) and FLT3.

Molecular Weight	234.25
Formula	C15H10N2O
CAS Number	34823-86-4
Form	Solid
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related FLT3 Products
Quizartinib (AC220) Quizartinib (AC220) is a uniquely potent and selective FLT3 inhibitor.
KW-2449 KW-2449 is a novel multitargeted kinase inhibitor of FLT3, ABL and Aurora kinase with IC50 values of 6.6 nM, 14 nM and 48 nM.
Tandutinib Tandutinib (MLN518, CT53518) is an orally active multitargeted tyrosine kinase inhibitor of FLT3 (IC50 = 0.22 μM), and it also inhibits c-Kit and PDGFR with IC50 values of 0.17 μM and 0.20 μM, respectively. Tandutinib has the ability to cross the blood-brain barrier.
FF-10101 FF-10101 is a novel irreversible FLT3 inhibitor.
TCS 359 TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.

Catalog